Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook.
CSL reported a 3.4 percent increase in
first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)